{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T19:55:32Z","timestamp":1777492532852,"version":"3.51.4"},"reference-count":77,"publisher":"Public Library of Science (PLoS)","issue":"4","license":[{"start":{"date-parts":[[2014,4,8]],"date-time":"2014-04-08T00:00:00Z","timestamp":1396915200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0094205","type":"journal-article","created":{"date-parts":[[2014,4,8]],"date-time":"2014-04-08T21:49:31Z","timestamp":1396993771000},"page":"e94205","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":33,"title":["Mechanisms Controlling the Effects of Bevacizumab (Avastin) on the Inhibition of Early but Not Late Formed Corneal Neovascularization"],"prefix":"10.1371","volume":"9","author":[{"given":"Wei-Li","family":"Chen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yan-Ming","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hsiao-Sang","family":"Chu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chung-Tien","family":"Lin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lu-Ping","family":"Chow","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chih-Ta","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fung-Rong","family":"Hu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2014,4,8]]},"reference":[{"key":"ref1","first-page":"253","article-title":"Corneal neovascularization","volume":"1","author":"DG Cogan","year":"1962","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"ref2","first-page":"18","article-title":"Requirement for vascular endothelial growth factor in wound- and inflammation-related corneal neovascularization","volume":"39","author":"S Amano","year":"1998","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1097\/00003226-199811000-00008","article-title":"Angiogenesis in corneal diseases: histopathologic evaluation of 254 human corneal buttons with neovascularization","volume":"17","author":"C Cursiefen","year":"1998","journal-title":"Cornea"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/S0039-6257(98)00035-6","article-title":"Ocular neovascularization: an epidemiologic review","volume":"43","author":"P Lee","year":"1998","journal-title":"Surv Ophthalmol"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1097\/00055735-200108000-00002","article-title":"Corneal neovascularization","volume":"12","author":"JH Chang","year":"2001","journal-title":"Curr Opin Ophthalmol"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"2666","DOI":"10.1167\/iovs.03-1380","article-title":"Inhibition of hemangiogenesis and lymphangiogenesis after normal-risk corneal transplantation by neutralizing VEGF promotes graft survival","volume":"45","author":"C Cursiefen","year":"2004","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"2411","DOI":"10.1167\/iovs.09-3745","article-title":"Effects of topical and subconjunctival bevacizumab in high-risk corneal transplant survival","volume":"51","author":"MH Dastjerdi","year":"2010","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"1300","DOI":"10.1016\/j.ophtha.2010.01.039","article-title":"Corneal neovascularization as a risk factor for graft failure and rejection after keratoplasty: an evidence-based meta-analysis","volume":"117","author":"B Bachmann","year":"2010","journal-title":"Ophthalmology"},{"key":"ref9","first-page":"604","article-title":"Corneal neovascularization after penetrating keratoplasty","volume":"14","author":"MR Dana","year":"1995","journal-title":"Cornea"},{"key":"ref10","first-page":"274","article-title":"Corneal neovascularization induced by xenografts or chemical cautery. Inhibition by cyclosporin A","volume":"38","author":"U Benelli","year":"1997","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"ref11","first-page":"2514","article-title":"Expression of vascular endothelial growth factor and its receptors in inflamed and vascularized human corneas","volume":"41","author":"W Philipp","year":"2000","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"e36451","DOI":"10.1371\/journal.pone.0036451","article-title":"Human tears reveal insights into corneal neovascularization","volume":"7","author":"N Zakaria","year":"2012","journal-title":"PLoS One"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1016\/S0002-9440(10)62355-3","article-title":"Spontaneous corneal hemangiogenesis and lymphangiogenesis in mice with destrinmutation depend on VEGFR3 signaling","volume":"166","author":"C Cursiefen","year":"2005","journal-title":"Am J Pathol"},{"key":"ref14","first-page":"264","article-title":"Corneal angiogenic privilege: angiogenic and antiangiogenic factors in corneal avascularity, vasculogenesis, and wound healing (an American Ophthalmological Society thesis)","volume":"104","author":"DT Azar","year":"2006","journal-title":"Trans Am Ophthalmol Soc"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1002\/(SICI)1099-0895(199703)13:1<37::AID-DMR174>3.0.CO;2-K","article-title":"Vascular endothelial growth factor in ocular neovascularization and proliferative diabetic retinopathy","volume":"13","author":"JW Miller","year":"1997","journal-title":"Diabetes Metab Rev"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1159\/000268033","article-title":"Vascular endothelial growth factor and the eye: Biochemical mechanisms of action and implications for novel therapies","volume":"29","author":"LP Aiello","year":"1997","journal-title":"Ophthalmic Res"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1076\/ceyr.23.1.1.5422","article-title":"Corneal epithelial VEGF and cytochrome P450 4B1 expression in a rabbit model of closed eye contact lens wear","volume":"23","author":"V Mastyugin","year":"2001","journal-title":"Curr Eye Res"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1126\/science.1312256","article-title":"The fms-like tyrosine kinase, a receptor for vascular endothelial growth factor","volume":"255","author":"C de Vries","year":"1992","journal-title":"Science"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"1579","DOI":"10.1016\/0006-291X(92)90483-2","article-title":"Identification of the KDR tyrosine kinase as a receptor for vascular endothelial cell growth factor","volume":"187","author":"BI Terman","year":"1992","journal-title":"Biochem Biophys Res Commun"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1016\/0092-8674(93)90573-9","article-title":"High affinity VEGF binding and developmental expression suggest Flk-1 as a major regulator of vasculogenesis and angiogenesis","volume":"72","author":"B Millauer","year":"1993","journal-title":"Cell"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"7533","DOI":"10.1073\/pnas.90.16.7533","article-title":"Fetal liver kinase 1 is a receptor for vascular endothelial growth factor and is selectively expressed in vascular endothelium","volume":"90","author":"TP Quinn","year":"1993","journal-title":"Proc Natl Acad Sci USA"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1016\/j.ajo.2007.11.003","article-title":"Inhibition of corneal neovascularization by subconjunctival bevacizumab in an animal model","volume":"145","author":"M Papathanassiou","year":"2008","journal-title":"Am J Ophthalmol"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"1659","DOI":"10.1167\/iovs.08-1997","article-title":"Subconjunctival injection of bevacizumab (Avastin) on corneal neovascularization in different rabbit models of corneal angiogenesis","volume":"50","author":"WL Chen","year":"2009","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1097\/ICO.0b013e318160d019","article-title":"Effect of subconjunctival bevacizumab (Avastin) on experimental corneal neovascularization in guinea pigs","volume":"27","author":"V Hurmeric","year":"2008","journal-title":"Cornea"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1097\/ICO.0b013e31815cf67d","article-title":"Inhibition of experimental corneal neovascularization by using subconjunctival injection of bevacizumab (Avastin)","volume":"27","author":"TI Kim","year":"2008","journal-title":"Cornea"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1111\/j.1442-9071.2007.01572.x","article-title":"Bevacizumab inhibits corneal neovascularization in an alkali burn induced model of corneal angiogenesis","volume":"35","author":"H Hosseini","year":"2007","journal-title":"Clin Experiment Ophthalmol"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"6277","DOI":"10.1167\/iovs.09-4571","article-title":"Early but not late treatment with bevacizumab (Avastin) can inhibit corneal neovascularization and conjunctivalization in rabbit limbal insufficiency","volume":"51","author":"CT Lin","year":"2010","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"S26","DOI":"10.1097\/ICO.0b013e3181ae8ff4","article-title":"Bevacizumab for the Treatment of Corneal Neovascularization","volume":"28","author":"WL Chen","year":"2009","journal-title":"Cornea"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1097\/ICO.0b013e3181e458c5","article-title":"Subconjunctival Injection of Bevacizumab in the Treatment of Corneal Neovascularization Associated with Lipid Deposition","volume":"30","author":"HS Chu","year":"2011","journal-title":"Cornea"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1167\/iovs.07-1175","article-title":"Interaction between bevacizumab and murine VEGF-A: a reassessment","volume":"49","author":"L Yu","year":"2008","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"2335","DOI":"10.1056\/NEJMoa032691","article-title":"Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer","volume":"350","author":"H Hurwitz","year":"2004","journal-title":"N Engl J Med"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"1695.e1","DOI":"10.1016\/j.ophtha.2006.05.064","article-title":"Intravitreal bevacizumab (Avastin) in the treatment of proliferative diabetic retinopathy","volume":"113","author":"RL Avery","year":"2006","journal-title":"Ophthalmology"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1007\/s00417-010-1315-z","article-title":"A review of clinical trials of anti-VEGF agents for diabetic retinopathy","volume":"248","author":"BP Nicholson","year":"2010","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1016\/j.ophtha.2010.03.045","article-title":"A prospective randomized trial of intravitreal bevacizumab or laser therapy in the management of diabetic macular edema. (BOLT study) 12-month data: report 2","volume":"117","author":"M Michaelides","year":"2010","journal-title":"Ophthalmology"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"1368","DOI":"10.1136\/bjo.2005.066431","article-title":"Bevacizumab suppresses choroidal neovascularisation caused by pathological myopia","volume":"89","author":"QD Nguyen","year":"2005","journal-title":"Br J Ophthalmol"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1016\/j.ophtha.2005.02.007","article-title":"Systemic bevacizumab (Avastin) therapy for neovascular age-related macular degeneration twelve-week results of an uncontrolled open-label clinical study","volume":"112","author":"S Michels","year":"2005","journal-title":"Ophthalmology"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/j.ophtha.2005.11.019","article-title":"Intravitreal bevacizumab (Avastin) for neovascular age-related macular degeneration","volume":"113","author":"RL Avery","year":"2006","journal-title":"Ophthalmology"},{"key":"ref38","first-page":"866","article-title":"Therapeutic anti-VEGF in age-related macular degeneration: Ranibizumab and Bevacizumab controversy","volume":"92","author":"SF Moreno","year":"2008","journal-title":"Br J Ophthalmol"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1136\/bjo.2006.107912","article-title":"Inhibition of experimental corneal neovascularisation by bevacizumab (Avastin)","volume":"91","author":"RP Manzano","year":"2007","journal-title":"Br J Ophthalmol"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"e33","DOI":"10.1016\/j.ophtha.2008.02.013","article-title":"The effect of topical bevacizumab on corneal neovascularization","volume":"115","author":"SW Kim","year":"2008","journal-title":"Ophthalmology"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1080\/02713680701799101","article-title":"Subconjunctival bevacizumab injection for corneal neovascularization in recurrent pterygium","volume":"33","author":"I Bahar","year":"2008","journal-title":"Curr Eye Res"},{"key":"ref42","first-page":"161","article-title":"Vitreous and plasma concentrations of apelin and vascular endothelial growth factor after intravitreal bevacizumab in eyes with proliferative diabetic retinopathy","volume":"31","author":"J Qian","year":"2011","journal-title":"Retina"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1038\/cdd.2009.152","article-title":"VEGF-dependent tumor angiogenesis requires inverse and reciprocal regulation of VEGFR1 and VEGFR2","volume":"17","author":"Z Zhang","year":"2010","journal-title":"Cell Death Differ"},{"key":"ref44","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1097\/IAE.0b013e3181bd2d7b","article-title":"Histology of fibrovascular membranes of proliferative diabetic retinopathy after intravitreal injection of bevacizumab","volume":"30","author":"T Kubota","year":"2010","journal-title":"Retina"},{"key":"ref45","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1136\/bjo.87.1.101","article-title":"Pericyte recruitment in human corneal angiogenesis: an ultrastructural study with clinicopathological correlation","volume":"87","author":"C Cursiefen","year":"2003","journal-title":"Br J Ophthalmol"},{"key":"ref46","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.exer.2007.10.013","article-title":"Pericytes and ocular diseases","volume":"86","author":"R Motiej\u016bnaite","year":"2008","journal-title":"Exp Eye Res"},{"key":"ref47","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/S0002-9440(10)63809-6","article-title":"Tumor vessel development and maturation impose limits on the effectiveness of anti-vascular therapy","volume":"162","author":"MS Gee","year":"2003","journal-title":"Am J Pathol"},{"key":"ref48","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1023\/A:1011965307612","article-title":"Contractile proteins in pericytes at the blood-brain and blood-retinal barriers","volume":"30","author":"R Bandopadhyay","year":"2001","journal-title":"J Neurocytol"},{"key":"ref49","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1177\/37.3.2918221","article-title":"\u03b1-Smooth muscle actin, a different marker of smooth muscle cells, is present in microfilamentous bundles of pericytes","volume":"37","author":"O Skalli","year":"1989","journal-title":"J Histochem Cytochem"},{"key":"ref50","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1186\/1476-4598-9-209","article-title":"Tumor cell-derived PDGF-B potentiates mouse mesenchymal stem cells-pericytes transition and recruitment through an interaction with NRP-1","volume":"9","author":"K Dhar","year":"2010","journal-title":"Mol Cancer"},{"key":"ref51","doi-asserted-by":"crossref","first-page":"5109","DOI":"10.1158\/0008-5472.CAN-09-4245","article-title":"The absence of pericytes does not increase the sensitivity of tumor vasculature to vascular endothelial growth factor-A blockade","volume":"70","author":"MH Nisancioglu","year":"2010","journal-title":"Cancer Res"},{"key":"ref52","first-page":"1393","article-title":"Expression of the high molecular weight melanoma-associated antigen by pericytes during angiogenesis in tumors and in healing wounds","volume":"136","author":"RO Schlingemann","year":"1990","journal-title":"Am J Pathol"},{"key":"ref53","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1369\/jhc.5A6871.2006","article-title":"AM-3K, an anti-macrophage antibody, recognizes CD163, a molecule associated with an anti-inflammatory macrophage phenotype","volume":"54","author":"Y Komohara","year":"2006","journal-title":"J Histochem Cytochem"},{"key":"ref54","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1002\/(SICI)1096-9896(199602)178:2<207::AID-PATH427>3.0.CO;2-G","article-title":"AM-3K, a novel monoclonal antibody specific for tissue macrophages and its application to pathological investigation","volume":"178","author":"L Zeng","year":"1996","journal-title":"J Pathol"},{"key":"ref55","doi-asserted-by":"crossref","first-page":"3051","DOI":"10.1167\/iovs.06-1083","article-title":"Endogenous TNFalpha suppression of neovascularization in corneal stroma in mice","volume":"48","author":"S Fujita","year":"2007","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"ref56","doi-asserted-by":"crossref","first-page":"2545","DOI":"10.1167\/iovs.06-0570","article-title":"Bevacizumab as a potent inhibitor of inflammatory corneal angiogenesis and lymphangiogenesis","volume":"48","author":"F Bock","year":"2007","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"ref57","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1167\/iovs.09-3420","article-title":"Impaired angiogenic response in the corneas of mice lacking osteopontin","volume":"51","author":"N Fujita","year":"2010","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"ref58","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.ajo.2010.03.016","article-title":"Histopathology of neovascular tissue from eyes with proliferative diabetic retinopathy after intravitreal bevacizumab injection","volume":"150","author":"R Kohno","year":"2010","journal-title":"Am J Ophthalmol"},{"key":"ref59","doi-asserted-by":"crossref","first-page":"1928","DOI":"10.1167\/iovs.05-1071","article-title":"The role of PDGF receptor inhibitors and PI3-kinase signaling in the pathogenesis of corneal neovascularization","volume":"47","author":"S Dell","year":"2006","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"ref60","first-page":"519","article-title":"Morphologic observations on experimental corneal vascularization in the rat","volume":"41","author":"JS McCracken","year":"1979","journal-title":"Lab Invest"},{"key":"ref61","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1136\/bjo.50.3.119","article-title":"Nomenclature of pericytes: intramural and extramural","volume":"50","author":"N Ashton","year":"1966","journal-title":"Br J Ophthalmol"},{"key":"ref62","first-page":"1625","article-title":"A model of angiogenesis in the mouse cornea. Invest","volume":"37","author":"BM Kenyon","year":"1996","journal-title":"Ophthalmol Vis Sci"},{"key":"ref63","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1038\/nm1095-1024","article-title":"Vascular endothelial growth factor acts as a survival factor for newly formed retinal vessels and has implications for retinopathy of prematurity","volume":"1","author":"T Alon","year":"1995","journal-title":"Nat Med"},{"key":"ref64","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1172\/JCI5028","article-title":"Selective ablation of immature blood vessels in established human tumors follows vascular endothelial growth factor withdrawal","volume":"103","author":"LE Benjamin","year":"1999","journal-title":"J Clin Invest"},{"key":"ref65","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.1242\/dev.125.9.1591","article-title":"A plasticity window for blood vessel remodelling is defined by pericyte coverage of the preformed endothelial network and is regulated by PDGF-B and VEGF","volume":"125","author":"LE Benjamin","year":"1998","journal-title":"Development"},{"key":"ref66","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1172\/JCI6127","article-title":"Blood vessel maturation: vascular development comes of age","volume":"103","author":"DC Darland","year":"1999","journal-title":"J Clin Invest"},{"key":"ref67","first-page":"1385","article-title":"Analysis of blood vessel maturation processes during cyclic ovarian angiogenesis","volume":"78","author":"V Goede","year":"1998","journal-title":"Lab Invest"},{"key":"ref68","first-page":"87","article-title":"Comparison of the neovascular efects of stimulated macrophages and neutrophils in autologous rabbit corneas","volume":"120","author":"JW Moore 3rd","year":"1985","journal-title":"Am J Pathol"},{"key":"ref69","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1097\/ICO.0b013e31823f8b40","article-title":"Activated macrophages induce neovascularization through upregulation of MMP-9 and VEGF in rat corneas","volume":"31","author":"ZR Li","year":"2012","journal-title":"Cornea"},{"key":"ref70","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1387\/ijdb.103227sn","article-title":"The interplay between macrophages and angiogenesis in development, tissue injury and regeneration","volume":"55","author":"S Nucera","year":"2011","journal-title":"Int J Dev Biol"},{"key":"ref71","doi-asserted-by":"crossref","first-page":"529","DOI":"10.2353\/ajpath.2006.050255","article-title":"Monocytes\/macrophages cooperate with progenitor cells during neovascularization and tissue repair: conversion of cell columns into fibrovascular bundles","volume":"168","author":"M Anghelina","year":"2006","journal-title":"Am J Pathol"},{"key":"ref72","doi-asserted-by":"crossref","first-page":"e13440","DOI":"10.1371\/journal.pone.0013440","article-title":"IQGAP1 is involved in post-ischemic neovascularization by regulating angiogenesis and macrophage infiltration","volume":"5","author":"N Urao","year":"2010","journal-title":"PLoS One"},{"key":"ref73","doi-asserted-by":"crossref","first-page":"2795","DOI":"10.1002\/ijc.22217","article-title":"Inhibition of carcinoma cell-derived VEGF reduces inflammatory characteristics in xenograft carcinoma","volume":"119","author":"AV Salnikov","year":"2006","journal-title":"Int J Cancer"},{"key":"ref74","doi-asserted-by":"crossref","first-page":"e7669","DOI":"10.1371\/journal.pone.0007669","article-title":"Cytokine levels correlate with immune cell infiltration after anti-VEGF therapy in preclinical mouse models of breast cancer","volume":"4","author":"CL Roland","year":"2009","journal-title":"PLoS One"},{"key":"ref75","doi-asserted-by":"crossref","first-page":"4340","DOI":"10.1158\/0008-5472.CAN-07-6705","article-title":"Vascular endothelial growth factor receptor 2 mediates macrophage infiltration into orthotopic pancreatic tumors in mice","volume":"68","author":"SP Dineen","year":"2008","journal-title":"Cancer Res"},{"key":"ref76","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1080\/02713680902919557","article-title":"Mediators of neovascularization and the hypoxic cornea","volume":"34","author":"A Safvati","year":"2009","journal-title":"Curr Eye Res"},{"key":"ref77","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1016\/j.ajo.2010.04.024","article-title":"Inhibition of corneal neovascularization by topical bevacizumab (anti-VEGF) and sunitinib (anti-VEGF and anti-PDGF) in an animal model","volume":"150","author":"JJ P\u00e9rez-Santonja","year":"2010","journal-title":"Am J Ophthalmol"}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0094205","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T03:50:49Z","timestamp":1648785049000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0094205"}},"subtitle":[],"editor":[{"given":"Fu-Shin","family":"Yu","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2014,4,8]]},"references-count":77,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2014,4,8]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0094205","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,4,8]]}}}